AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $400,000 | +0.3% | 52,184 | -19.2% | 0.00% | -66.7% |
| Q1 2020 | $399,000 | -79.5% | 64,566 | -59.7% | 0.00% | -75.0% |
| Q4 2019 | $1,948,000 | +524.4% | 160,080 | +492.6% | 0.01% | +500.0% |
| Q3 2019 | $312,000 | -49.5% | 27,013 | -33.6% | 0.00% | -71.4% |
| Q4 2018 | $618,000 | -44.6% | 40,685 | -27.1% | 0.01% | -12.5% |
| Q3 2018 | $1,116,000 | -25.9% | 55,800 | -31.9% | 0.01% | -46.7% |
| Q2 2017 | $1,507,000 | -33.8% | 81,910 | -18.9% | 0.02% | -28.6% |
| Q1 2017 | $2,276,000 | +385.3% | 100,949 | +549.5% | 0.02% | +133.3% |
| Q4 2015 | $469,000 | -69.6% | 15,543 | -60.0% | 0.01% | -71.0% |
| Q3 2015 | $1,545,000 | – | 38,881 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |